TABLE 1.
HIV strain | Medium | Enhancement effect of:
|
|
---|---|---|---|
Buffer | Anti-cathepsin D antibody | ||
HIV-1 IIIb | Vaginal fluid | 1.6 | 1.1 |
Cathepsin D | 1.8 | 1 | |
Milk | 1.4 | 1 | |
SI 121 | Vaginal fluid | 2.6 | 1.4 |
Cathepsin D | 1.5 | 1 | |
Milk | 1.6 | 0.8 | |
NSI 114 | Vaginal fluid | 2.5 | 1.7 |
Cathepsin D | 2.1 | 1.5 | |
Milk | 1.8 | 0.7 |
Vaginal fluid diluted 1:10, milk diluted 1:10, and cathepsin D at 2 mg/ml were incubated for 10 min at 37°C with polyclonal anti-cathepsin D antibody (Biogenesis) diluted 1:500 or buffer. The mixtures were further incubated for 10 min with the three virus strains and then inoculated into lymphocyte cultures. After 10 days, levels of HIV p24 in the supernatant were measured, and enhancement was estimated by the ratio of results for treated viruses to nontreated viruses.